Artikel
Lizenziert
Nicht lizenziert
Erfordert eine Authentifizierung
The prevalence and risk factors for gallstone disease
-
Eun-Hyung Yoo
Veröffentlicht/Copyright:
5. Juni 2009
Abstract
Gallstone disease is one of the most prevalent gastrointestinal disorders. In addition, the costs associated with the diagnosis and treatment of gallstone disease have been rapidly increasing. The etiology and pathogenesis of gallstone disease remains incompletely understood. Gallstone formation may result from a complex interaction of genetic and environmental factors. This article reviews the prevalence and risk factors associated with gallstone disease. Understanding the pathogenesis of gallstone disease could lead to the development of better therapeutic and preventive strategies for dealing with this disease.
Clin Chem Lab Med 2009;47:795–807.
Received: 2009-1-19
Accepted: 2009-4-21
Published Online: 2009-06-05
Published in Print: 2009-07-01
©2009 by Walter de Gruyter Berlin New York
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Artikel in diesem Heft
- Editorials
- Change through continuity
- EFCC and Labs are Vital announce an Award for Outcomes Research in Laboratory Medicine
- Review
- The prevalence and risk factors for gallstone disease
- Opinion Paper
- Measurement uncertainty of test kit results – the ELISA example
- Genetics and Molecular Diagnostics
- Expression of RhoA and RhoC in colorectal carcinoma and its relations with clinicopathological parameters
- High-sensitive microarray substrates specifically designed to improve sensitivity for the identification of fetal paternally inherited sequences in maternal plasma
- A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency
- The haptoglobin phenotype is associated with the Epstein-Barr virus antibody titer
- General Clinical Chemistry and Laboratory Medicine
- Evaluation of analytical performance of the Pathfast® cardiac troponin I
- Diagnostic performance of the ARCHITECT C-Peptide immunoassay
- Clinical significance of anti-cyclic citrullinated peptide antibodies in Egyptian patients with chronic hepatitis C virus genotype IV infection
- Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis
- Therapeutic drug monitoring and drugs of abuse testing on the cobas® 6000 analyzer series: analytical performance under routine-like conditions
- Is serum γ-glutamyltransferase an exposure marker of xenobiotics? Empirical evidence with polycylic aromatic hydrocarbon
- Reference Values and Biological Variations
- Gender difference and determinants of C-reactive protein level in Korean adults
- Cancer Diagnostics
- Quantitative telomerase activity in circulating human leukocytes: utility of real-time telomeric repeats amplification protocol (RQ-TRAP) in a clinical/epidemiological setting
- Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers
- Letters to the Editor
- Hyperleukocytosis: pseudohyperkalaemia and other biochemical abnormalities in hyperleukocytosis
- Review of the prevalence of macroprolactinaemia in a South African hospital
- A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe Against Cancer Program
- Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions
- Doubt on prevention of false-positive results of cardiac troponin I by recentrifugation
- Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease
Schlagwörter für diesen Artikel
bile;
cholelithiasis;
gallbladder;
gallstone;
prevalence;
risk factors
Artikel in diesem Heft
- Editorials
- Change through continuity
- EFCC and Labs are Vital announce an Award for Outcomes Research in Laboratory Medicine
- Review
- The prevalence and risk factors for gallstone disease
- Opinion Paper
- Measurement uncertainty of test kit results – the ELISA example
- Genetics and Molecular Diagnostics
- Expression of RhoA and RhoC in colorectal carcinoma and its relations with clinicopathological parameters
- High-sensitive microarray substrates specifically designed to improve sensitivity for the identification of fetal paternally inherited sequences in maternal plasma
- A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency
- The haptoglobin phenotype is associated with the Epstein-Barr virus antibody titer
- General Clinical Chemistry and Laboratory Medicine
- Evaluation of analytical performance of the Pathfast® cardiac troponin I
- Diagnostic performance of the ARCHITECT C-Peptide immunoassay
- Clinical significance of anti-cyclic citrullinated peptide antibodies in Egyptian patients with chronic hepatitis C virus genotype IV infection
- Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis
- Therapeutic drug monitoring and drugs of abuse testing on the cobas® 6000 analyzer series: analytical performance under routine-like conditions
- Is serum γ-glutamyltransferase an exposure marker of xenobiotics? Empirical evidence with polycylic aromatic hydrocarbon
- Reference Values and Biological Variations
- Gender difference and determinants of C-reactive protein level in Korean adults
- Cancer Diagnostics
- Quantitative telomerase activity in circulating human leukocytes: utility of real-time telomeric repeats amplification protocol (RQ-TRAP) in a clinical/epidemiological setting
- Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers
- Letters to the Editor
- Hyperleukocytosis: pseudohyperkalaemia and other biochemical abnormalities in hyperleukocytosis
- Review of the prevalence of macroprolactinaemia in a South African hospital
- A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe Against Cancer Program
- Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions
- Doubt on prevention of false-positive results of cardiac troponin I by recentrifugation
- Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease
